 SEATTLE, April 05, 2022 GLOBE NEWSWIRE -- Adaptive Biotechnologies Corporation Nasdaq: ADPT a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the first quarter 2022 after market close on Wednesday, May 4, 2022. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time 4:30 p.m. Eastern Time. 